Jana Gevertz

Jana Gevertz has developed PK/PD mathematical models for optimizing cancer drug combinations and treatment schedules. Her work has revealed that treatment timing and sequencing can dramatically alter efficacy through pharmacological interactions and evolutionary dynamics. She has created computational frameworks for identifying synergistic drug combinations and optimal dosing strategies that minimize resistance emergence.